The impact of psychopharmacology on contemporary psychiatry

Canadian Journal of Psychiatry

Volumn 59, Issue 8, 2014, Pages 401-405

  Baldessarini, Ross J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Drug development; Practice; Psychiatric education; Psychopharmacology; Theory

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; IMIPRAMINE; IPRONIAZID; LITHIUM CARBONATE; MOOD STABILIZER;

ANESTHESIST; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; CLINICAL PRACTICE; CONTEMPORARY PSYCHIATRY; COST CONTROL; DEPRESSION; DISEASE CLASSIFICATION; DRUG INDUSTRY; EDITORIAL; FOLLOW UP; FUNCTIONAL NEUROIMAGING; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; MANAGED CARE; MANIA; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MOOD CHANGE; NEUROPHARMACOLOGY; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PATIENT CARE; PROFESSIONAL KNOWLEDGE; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIST; PSYCHIATRY; PSYCHOPHARMACOLOGY; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL PSYCHIATRY; STANDARD; SURGEON; WORK EXPERIENCE;

BRAIN; CANADA; EVIDENCE-BASED MEDICINE; FORECASTING; HUMANS; MENTAL DISORDERS; NEUROSCIENCES; PSYCHIATRY; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; RECURRENCE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84905972773     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371405900801     Document Type: Editorial

References (32)

1. Baldessarini RJ. Chemotherapy in psychiatry: the pharmacologic basis of treatments for major mental illness. 3rd ed. New York (NY): Springer Press; 2013. For the term pharmacocentric theorizing, p 21-24.
2. Healy D. Pharmageddon. Berkeley (CA): University of California Press; 2012.
3. Taylor MA. Hippocrates cried. New York (NY): Oxford University Press; 2013.
4. Gardner DM. Competent psychopharmacology. Can J Psychiatry. 2014;59(8):406-411.
5. Vázquez GH. The impact of psychopharmacology on contemporary clinical psychiatry. Can J Psychiatry. 2014;59(8):412-416.
6. Eisenberg L. Mindlessness and brainlessness in psychiatry. Br J Psychiatry. 1986;148(5):497-508. (Pubitemid 16042295)
7. Eisenberg L. Past, present, and future of psychiatry: personal reflections. Can J Psychiatry. 1997;42(7):705-713. (Pubitemid 127796600)
8. Kandel E, Schwartz J, Jessell T, et al. Principles of neural science. 5th ed. New York (NY): McGraw-Hill; 2013.
9. Baldessarini RJ. American biological psychiatry and psychopharmacology 1944-1994. Chapter 16. In: Menninger RW, Nemiah JC, editors. American psychiatry after World War II (1944-1994). Washington (DC): American Psychiatric Press; 2000. p 371-412. For the term pharmacocentric theorizing, p 392-397.
10. Brunton L, Chabner B, Knollman B, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 12th ed. New York (NY): McGraw Hill; 2010.
11. Musalek M, Larach-Walters V, Lépine J-P, et al. Psychopathology in the 21st century. World J Biol Psychiatry. 2010;11(7):844-851.
12. North CS, Yutzy SH. Goodwin and Guze's psychiatric diagnosis. 6th ed. New York (NY): Oxford University Press; 2010.
13. World Health Organization (WHO). International statistical classification of diseases and related health problems. 10th revision. Geneva (CH): WHO; 1994.
14. American Psychiatric Association (APA). Diagnostic and statistical manual of mental Ddsorders. 5th ed. Washington (DC): American Psychiatric Press; 2013.
15. De Leon J. DSM-5 and the research domain criteria: 100 years after Jaspers' General Psychopathology. Am J Psychiatry. 2013;171(4):1-3.
16. Salvatore P, Baldessarini RJ, Tohen M, et al. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2009;70(4):458-466.
17. Salvatore P, Baldessarini RJ, Tohen M, et al. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2011;72(2):183-193.
18. Østergaard SD, Jensen SOW, Bech P. Heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatr Scand. 2011;124(6):495-496.
19. Ghaemi SN. On depression, drugs, diagnosis and despair in the modern world. Baltimore (MD): Johns Hopkins University Press; 2013.
20. Leucht S, Hierl S, Kissling W, et al. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry. 2012;200(2):97-106.
21. Tsapakis EM, Soldani F, Tondo L, et al. Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry. 2008;193(1):10-17. (Pubitemid 351946803)
22. Yildiz A, Vieta E, Leucht S, et al. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology. 2011;36(2):375-389.
23. Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology. 2012;37(4):851-864.
24. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962.
25. Faedda GL, Tondo L, Baldessarini RJ, et al. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar mood disorders. Arch Gen Psychiatry. 1993;50(6):448-455. (Pubitemid 23169938)
26. Baldessarini RJ, Tondo L, Ghiani C, et al. Illness risk following rapid versus gradual discontinuation of antidepressants. Am J Psychiatry. 2010;167(8):934-941.
27. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499-507. (Pubitemid 43200344)
28. Viguera AC, Whitfield T, Baldessarini RJ, et al. Recurrences of bipolar disorder in pregnancy: prospective study of mood-stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817-1824. (Pubitemid 351739234)
29. Centorrino F, Goren JL, Hennen J, et al. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004;161(4):700-706. (Pubitemid 38445515)
30. Gallego JA, Bonetti J, Zhang J, et al. Prevalence and correlates of antipsychotic polypharmacy: systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res. 2012;138(1):18-28.
31. Kroken RA, Johnsen E. Is rational antipsychotic polytherapy feasible (selective review)? Curr Psychiatry Rep. 2012;14(3):244-251.
32. Thase ME. Antidepressant combinations: cutting edge psychopharmacology or passing fad? Curr Psychiatry Rep. 2013;15(10):403-404.